ZCM
NPTN

Zenyatta Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Zenyatta Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$1.54M – 55
2021
Q4 		$1.54M Buy
+100,000
New +$1.32M 0.58% 43

Other funds holding NPTN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Zenyatta Capital Management's NPTN Position: Q1 2022 in Review

Zenyatta Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 100,000 shares — an estimated $1.54M sold.

Zenyatta Capital Management first reported a position in NPTN in Q4 2021 and held it in 1 quarter. The position peaked at $1.54M in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • Zenyatta Capital Management reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • Zenyatta Capital Management sold 100,000 NEOPHOTONICS CORP shares in Q1 2022, an estimated $1.54M.
  • Zenyatta Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 1 quarter.
  • Zenyatta Capital Management's NEOPHOTONICS CORP position peaked at $1.54M in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Zenyatta Capital Management's 13F filing for Q1 2022, filed 10 May 2022.